CE-IVD received for STI test
Filed with ASX · · 1 page · English
advise that it has received CE-IVD registration for its3base™EasyScreen STI Genital Pathogen Detection Kit, which can detect 10 of the most commonly encountered sexually transmitted infections (STI’s) simultaneously. CE-IVD allows the kit to be marketed freely in the European Union and the UK. th TM John Melki, Genetic Signatures CEO, said, “This is the 5 3base™ EasyScreen Detection Kit to attain
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Supply agreement with major US customer
- First quarter sales update
- Preliminary Final Report
- Quarterly report and Appendix 4C
- S&P DJI Announces June 2020 Quarterly Rebalance
Later from Genetic Signatures
- Investor update
- 3base SARS-CoV-2 kit registered by TGA for saliva samples
- S&P DJI Announces March 2022 Quarterly Rebalance
- Public Health Wales Awards Enteric Testing Contract to GSS
- Clinical trial recruitment completed for US enteric kit
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures